View Older Stories View More Recent Stories

Aug 14, 2025 09:05AM Form 13F-NT Adage Capital Management For: Jun 30
Aug 14, 2025 09:04AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Jun 30
Aug 12, 2025 09:07AM Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:07AM Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:07AM Form SCHEDULE 13G/A TScan Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:07AM Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G/A IMMUNIC, INC. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G/A Janux Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G DBV Technologies S.A. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:06AM Form SCHEDULE 13G Adagio Medical Holdings, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:05AM Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:05AM Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:04AM Form SCHEDULE 13G/A ProQR Therapeutics N.V. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:04AM Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:04AM Form SCHEDULE 13G/A Seadrill Ltd Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:03AM Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:03AM Form SCHEDULE 13G/A Ensysce Biosciences, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:02AM Form SCHEDULE 13G/A Zeo Energy Corp. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:02AM Form SCHEDULE 13G/A Inozyme Pharma, Inc. Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:02AM Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:02AM Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:01AM Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Adage Capital Management, L.P.
Aug 12, 2025 09:01AM Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: Adage Capital Management, L.P.
Aug 11, 2025 04:30PM BBOT begins trading on Nasdaq after $382M SPAC merger completion
Aug 11, 2025 04:30PM BBOT Debuts as a Publicly Traded Company Focused on RAS-Pathway Malignances with a Potential to Realize the Full Promise of KRAS and PI3K Inhibition
Aug 11, 2025 08:31AM Equillium secures up to $50 million to advance inflammatory drug EQ504
Aug 11, 2025 08:30AM Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
Aug 7, 2025 06:30AM Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 5, 2025 06:30AM Shattuck Labs raises up to $103 million in oversubscribed private placement
Aug 5, 2025 06:30AM Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million
Aug 1, 2025 08:56AM Everest Medicines invests $30.9 million in I-MAB, raising stake to 16.1%
Aug 1, 2025 08:56AM Everest Medicines Expands Strategic Investment in I-MAB
Aug 1, 2025 08:01AM I-Mab prices $65 million offering of American depositary shares
Aug 1, 2025 08:00AM I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares
Jul 30, 2025 10:05AM UNITE 2025 Summit Spotlights HBCU Leaders and Institutions Advancing Educational Excellence
Jun 20, 2025 04:05PM Form SCHEDULE 13D/A GLYCOMIMETICS INC Filed by: Adage Capital Management, L.P.
Jun 17, 2025 11:45AM Medincell Publishes its Consolidated Annual Financial Results
Jun 3, 2025 04:01PM Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering
Jun 2, 2025 06:00AM atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
May 15, 2025 10:20AM Form 13F-HR ADAGE CAPITAL PARTNERS For: Mar 31
May 15, 2025 10:20AM Form 13F-NT Adage Capital Management For: Mar 31
May 12, 2025 09:08AM Form SCHEDULE 13G/A Aclaris Therapeutics, Filed by: Adage Capital Management, L.P.
May 12, 2025 09:08AM Form SCHEDULE 13G/A Seadrill Ltd Filed by: Adage Capital Management, L.P.
May 12, 2025 09:07AM Form SCHEDULE 13G/A ProQR Therapeutics N.V. Filed by: Adage Capital Management, L.P.
May 12, 2025 09:06AM Form SCHEDULE 13G Praxis Precision Medicin Filed by: Adage Capital Management, L.P.
May 12, 2025 09:06AM Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Adage Capital Management, L.P.
May 12, 2025 09:06AM Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: Adage Capital Management, L.P.
May 12, 2025 09:05AM Form SCHEDULE 13G Solid Biosciences Inc. Filed by: Adage Capital Management, L.P.
May 12, 2025 09:05AM Form SCHEDULE 13G Amylyx Pharmaceuticals, Filed by: Adage Capital Management, L.P.
May 12, 2025 09:04AM Form SCHEDULE 13G Ensysce Biosciences, Filed by: Adage Capital Management, L.P.
View More Recent Stories View Older Stories